|
|
|
Zimmer Biomet Holdings Inc (ZBH) |
|
|
|
| |
Zimmer Biomet Holdings Inc 's Yearly Sales Growth 5 Years |
| |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Revenue Annual Growth Rates Y/Y▼
|
Annual Revenue Annual Growth Rates Y/Y▼
|
ZBH Annual Revenue Growth |
2022
|
2021
|
2020
|
2019
|
2018
|
| Y / Y Annual Revenue Change |
-11.44 % |
11.56 % |
-12 % |
0.62 % |
1.39 % |
| Annual Revenue (in millions $) |
$6,939.90 |
$7,836.20 |
$7,024.50 |
$7,982.20 |
$7,932.90 |
| Annual Revenue Growth
Comment |
Zimmer Biomet Holdings Inc experienced detoriation of Annual Revenue for the fiscal year ended 2022 by -11.44% to $ 6,939.90 millions, compare to $ 7,836.20 in Annual Revenue reported in the previous year. The decline in company's annual Sales accelerated, from the 11.56 % gain, in the fiscal year ended 2021.
Zimmer Biomet Holdings Inc Annual Income Statement
|
|
You need to upgrade your Flash Player
|
| Companies with similar 2022 Annual Revenue within Healthcare Sector | Y/Y Sales Growth % | 2022 Annual Revenue | | Hca Healthcare Inc |  2.52 % | $ 60,233.000 millions | | Abbvie Inc | 3.30 % | $ 58,054.000 millions | | Novartis Ag |  -1.98 % | $ 51,828.000 millions | | Merck and Co Inc | 21.72 % | $ 59,283.000 millions | | Bristol myers Squibb Company | -0.49 % | $ 46,159.000 millions | | Abbott Laboratories | 1.34 % | $ 43,653.000 millions | | Astrazeneca Plc | 18.53 % | $ 44,351.000 millions | | 3m Company | -3.18 % | $ 34,229.000 millions | | Gsk Plc | -14.04 % | $ 29,324.000 millions | | Medtronic Plc | 5.21 % | $ 31,686.000 millions | | Eli Lilly And Company | 0.79 % | $ 28,541.400 millions | | Gilead Sciences Inc | -0.09 % | $ 27,281.000 millions | | Amgen Inc | 1.32 % | $ 26,323.000 millions | | Becton Dickinson And Company | -6.81 % | $ 18,870.000 millions | | Fresenius Medical Care Ag | 10.10 % | $ 21,725.779 millions | | Tenet Healthcare Corp | -1.60 % | $ 19,174.000 millions | | Sinovac Biotech Ltd | -92.30 % | $ 1,492.761 millions | | Koninklijke Philips Nv | 3.91 % | $ 19,966.240 millions | | Moderna Inc | 4.29 % | $ 19,263.000 millions | | Viatris Inc | -9.08 % | $ 16,262.700 millions | | Stryker Corp | 7.84 % | $ 18,449.000 millions | | Regeneron Pharmaceuticals Inc | -24.26 % | $ 12,172.900 millions | | Teva Pharmaceutical Industries Limited | -6.00 % | $ 14,925.000 millions | | Iqvia Holdings Inc | 3.86 % | $ 14,410.000 millions | | Baxter International Inc | 18.22 % | $ 15,113.000 millions | | Universal Health Services Inc | 5.99 % | $ 13,399.370 millions | | Henry Schein Inc | 1.98 % | $ 12,647.000 millions | | Community Health Systems Inc | -1.27 % | $ 12,211.000 millions | | Boston Scientific Corporation | 6.69 % | $ 12,683.000 millions | | Hologic Inc | -37.60 % | $ 3,293.100 millions | | Revvity Inc | -34.66 % | $ 3,311.822 millions | | Enovis Corp | -59.44 % | $ 1,563.101 millions | | Idexx Laboratories Inc | 4.73 % | $ 3,367.324 millions | | Endo International Plc | -22.55 % | $ 2,318.875 millions | | Incyte Corporation | 13.66 % | $ 3,394.635 millions | | Qiagen N v | -30.28 % | $ 2,081.035 millions | | Bio rad Laboratories Inc | -4.11 % | $ 2,802.249 millions | | The Cooper Companies Inc | 13.21 % | $ 3,308.400 millions | | West Pharmaceutical Services Inc | 1.94 % | $ 2,886.900 millions | | Teleflex Incorporated | -0.64 % | $ 2,791.041 millions | | Brookdale Senior Living Inc | 2.43 % | $ 2,777.318 millions | | Ensign Group Inc | 15.15 % | $ 3,025.468 millions | | Dr Reddy s Laboratories Limited | 8.94 % | $ 2,826.000 millions | | Envista Holdings Corporation | 2.43 % | $ 2,569.100 millions | | Acadia Healthcare Company Inc | 11.04 % | $ 2,725.621 millions | | Adapthealth Corp | 21.03 % | $ 2,970.595 millions | | Dexcom Inc | 18.83 % | $ 2,909.800 millions | | Bruker Corporation | 4.68 % | $ 2,530.700 millions | | Royalty Pharma Plc | -2.27 % | $ 2,237.215 millions | | Surgery Partners Inc | 14.11 % | $ 2,539.300 millions | | Lhc Group Inc | 2.84 % | $ 2,282.771 millions | | Amedisys Inc | 0.41 % | $ 2,223.199 millions | | Chemed Corporation | -0.23 % | $ 2,134.963 millions | | National Vision Holdings Inc | -3.56 % | $ 2,005.404 millions | | Amneal Pharmaceuticals Inc | 6.28 % | $ 2,200.708 millions | | Pediatrix Medical Group Inc | 3.19 % | $ 1,972.021 millions | | Biomarin Pharmaceutical Inc | 13.54 % | $ 2,096.039 millions | | Agilon Health Inc | 47.74 % | $ 2,708.211 millions | | Emergent Biosolutions Inc | -37.67 % | $ 1,117.500 millions | | Opko Health Inc | -43.40 % | $ 1,004.196 millions | | Quidelortho Corp | 92.34 % | $ 3,266.000 millions | | United Therapeutics Corporation | 14.90 % | $ 1,936.300 millions | | Healthcare Services Group Inc | 2.99 % | $ 1,690.176 millions | | Cano Health Inc | 70.17 % | $ 2,738.916 millions | | Seagen Inc | 24.65 % | $ 1,962.412 millions | | Integra Lifesciences Holdings Corp | 0.97 % | $ 1,557.666 millions | | Exelixis Inc | 12.34 % | $ 1,611.062 millions | | Oak Street Health Inc | 50.84 % | $ 2,160.900 millions | | Msa Safety Inc | 9.07 % | $ 1,527.831 millions | | Radnet Inc | 8.01 % | $ 1,430.061 millions | | Icu Medical Inc | 73.18 % | $ 2,279.997 millions | | Masimo Corp | 64.25 % | $ 2,035.800 millions | | Integer Holdings Corporation | 12.69 % | $ 1,376.096 millions | | Beigene Ltd | 20.32 % | $ 1,415.921 millions | | Alkermes Plc | -5.29 % | $ 1,111.795 millions | | Novavax inc | 72.86 % | $ 1,981.872 millions | | Medpace Holdings Inc | 27.76 % | $ 1,459.996 millions | | Nuvasive Inc | 5.54 % | $ 1,201.942 millions | | Neurocrine Biosciences Inc | 31.33 % | $ 1,488.700 millions | | Insulet Corporation | 18.85 % | $ 1,305.300 millions | | Vir Biotechnology Inc | 47.49 % | $ 1,615.797 millions | | Merit Medical Systems Inc | 7.08 % | $ 1,150.981 millions | | National Healthcare Corp | 1.02 % | $ 1,085.738 millions | | Livanova Plc | -1.35 % | $ 1,021.805 millions | | Zimvie Inc | -9.96 % | $ 913.862 millions | | Conmed Corporation | 3.47 % | $ 1,045.472 millions | | Privia Health Group Inc | 40.37 % | $ 1,356.660 millions | | Globus Medical Inc | 6.68 % | $ 1,022.843 millions | | Prestige Consumer Healthcare Inc | 15.16 % | $ 1,086.812 millions | | Sotera Health Company | 7.73 % | $ 1,003.687 millions | | Bio techne Corp | 18.69 % | $ 1,105.599 millions | | Invacare Holdings Corporation | -15.02 % | $ 741.733 millions | | Haemonetics Corporation | 14.02 % | $ 992.502 millions | | Addus Homecare Corporation | 10.07 % | $ 951.120 millions | | Abiomed Inc | 21.72 % | $ 1,031.753 millions | | Alnylam Pharmaceuticals Inc | 22.87 % | $ 1,037.418 millions | | Phibro Animal Health Corporation | 13.09 % | $ 942.261 millions | | Maravai Lifesciences Holdings Inc | 10.51 % | $ 883.001 millions | | Signify Health Inc | 4.14 % | $ 805.500 millions | | Penumbra Inc | 13.39 % | $ 847.133 millions | | Avanos Medical Inc | 10.22 % | $ 820.000 millions | | Tandem Diabetes Care Inc | 14.10 % | $ 801.217 millions | | Sarepta Therapeutics Inc | 33.10 % | $ 933.013 millions | | Evotec Se | 21.53 % | $ 841.622 millions | | Repligen Corp | 19.55 % | $ 801.536 millions | | Lifestance Health Group Inc | 28.79 % | $ 859.542 millions | | Innovage Holding Corp | 9.58 % | $ 698.640 millions | | Natera Inc | 31.20 % | $ 820.222 millions | | 1life Healthcare Inc | 67.74 % | $ 1,045.547 millions | | Ptc Therapeutics inc | 29.74 % | $ 698.801 millions | | Progyny Inc | 57.20 % | $ 786.913 millions | | P3 Health Partners Inc | 113.65 % | $ 1,049.471 millions | | Dynavax Technologies Corporation | 64.61 % | $ 721.683 millions | | Lantheus Holdings Inc | 120.00 % | $ 935.061 millions | | Akumin Inc | 77.91 % | $ 749.631 millions |
Other Companies within Healthcare Sector and their 2022 Sales |
Y/Y Annual Revenue Growth % |
2022 Sales | | Fulgent Genetics Inc | -37.70 % | $ 618.968 millions | | Crispr Therapeutics Ag | -99.89 % | $ 1.198 millions | | Ionis Pharmaceuticals Inc | -27.53 % | $ 587.367 millions | | Myriad Genetics Inc | -1.74 % | $ 678.400 millions | | Smiledirectclub Inc | -26.22 % | $ 470.743 millions | | Ati Physical Therapy Inc | 1.28 % | $ 635.671 millions | | Cue Health Inc | -21.84 % | $ 483.476 millions | | Amarin Corp Plcuk | -58.49 % | $ 242.484 millions | | Supernus Pharmaceuticals inc | 15.20 % | $ 667.238 millions | | Taro Pharmaceutical Industries Ltd | 2.37 % | $ 561.334 millions |
|
